Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
News
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/a2/d0/2e/a2d02e38-ee60-a2a4-bf5c-e6d951b93b39/mza_3048579604930026653.jpg/600x600bb.jpg
ATTD: Advanced Technologies and Treatments for Diabetes
ATTD on UNLOK
41 episodes
1 day ago
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.
Show more...
Life Sciences
Science
RSS
All content for ATTD: Advanced Technologies and Treatments for Diabetes is the property of ATTD on UNLOK and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43275051/43275051-1742207209346-f8b3edee978b4.jpg
Toward the Cure of Type 1 Diabetes, ATTD 2025 Conference Catch-Up
ATTD: Advanced Technologies and Treatments for Diabetes
28 minutes 41 seconds
7 months ago
Toward the Cure of Type 1 Diabetes, ATTD 2025 Conference Catch-Up

In this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed at advancing beta cell replacement and ultimately finding a cure for type 1 diabetes.

Join us as we summarize key takeaways from these thought-provoking presentations:

  • Biomaterials to Aid Beta Cell Replacement - Current and Future Perspectives – Dr. Victoria Salem
  • New Strategies for Curative Therapies for Diabetes – Prof. Stefan Bornstein
  • Update on Efforts to Interdict Type 1 Diabetes – Dr. Desmond Schatz


This episode is an essential listen for endocrinologists, diabetes researchers, clinicians, and healthcare professionals interested in the latest advances in curative therapies, including gene therapy, biomaterials, and novel treatments aimed at reversing type 1 diabetes.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.

https://attd.kenes.com

ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.